Back Pain Doctor
Osteoarthritis of the Elbow
Written by Dr Joshua Hatch, Musculoskeletal GP, RACGP Fellow, Diploma in Musculoskeletal Medicine (FSEM UK).
Osteoarthritis of the elbow occurs when the cartilage lining the joint wears out or is damaged. It can follow a previous injury such as a fracture or dislocation, but most often it results from normal wear with age and years of activity. The elbow is one of the least commonly affected joints, because its well-matched surfaces and strong ligaments tolerate large forces well.
Assessment focuses on confirming the diagnosis from the history, examination and a plain X-ray, and on checking for features that change management: locking from loose fragments, significant loss of movement, or ulnar nerve irritation causing numbness in the ring and little fingers. A history of previous elbow injury or heavy occupational load is often relevant.
First-line care is usually simple analgesia, activity and load modification, and a physiotherapy program to maintain strength and range of motion, with a corticosteroid injection as a short-term adjunct where appropriate. When conservative measures no longer control symptoms, orthopaedic referral is appropriate to discuss arthroscopy or, in advanced cases, joint replacement.
Common symptoms
- Elbow pain and gradual loss of range of motion
- A grating sensation when bending or rotating the arm
- Locking or catching from loose fragments in the joint
- Later, numbness or tingling in the ring and little fingers
Commonly seen in
Evidence for twelve treatment options in osteoarthritis of the elbow
This is not a fixed ladder or a package of treatments. Every option is assessed independently against this diagnosis, including treatments with limited direct research that may still be reasonable for a clearly defined tissue target. The evidence level, likely benefit, risks, cost and alternatives are weighed at consultation.
Foundation: diagnosis, education and rehabilitation
The part of care with the broadest relevance. For many people it is enough on its own; other options are judged against it, not automatically added after it.
Diagnosis, education and progressive rehabilitation Working out what is driving the pain, explaining what your imaging does and does not mean, and building a graded loading plan you can actually follow. Core care
What it involves
Assessment to identify the likely pain source, an explanation of what the diagnosis means, adjustment of the loads that aggravate it, and a progressive strength and conditioning plan, with weight management where that is clinically relevant.
What the evidence shows
Exercise is the core treatment, and it performs as well as the tablets. A network meta-analysis of 152 randomised trials and 17,431 patients found exercise gave the same pain relief and functional improvement as oral anti-inflammatories and paracetamol, with a far better safety profile (Weng, Br J Sports Med 2023). EULAR (Moseng, Ann Rheum Dis 2024) and the American College of Rheumatology (Kolasinski, Arthritis Rheumatol 2020) both make exercise, education and weight management the core of non-pharmacological care. An individual-participant meta-analysis of 31 trials and 4,241 patients is clear about the size of it: the average effect is small and of questionable clinical importance, and those with more pain and worse function at the start benefit most (Holden, Lancet Rheumatol 2023).
Pairing reviewed 2026-09-02.
Where it fits
Worth being straight about: the average effect is modest, and it is larger for people who are struggling more to begin with. What it does have over the alternatives is that it is safe to keep doing, and it works on the things a joint injection cannot: strength, capacity and weight.
Muscle and symptom-modifying options
Useful only when the examination identifies the tissue they target or when short-term pain control creates a useful rehabilitation window.
Wet needling and trigger point injection (trigger point injection) A fine needle into a tender band of muscle, with a small volume of dilute glucose solution injected through it. Only if relevant
What it involves
The needle is placed into the tender muscle band and a small volume of 5% glucose with a very dilute local anaesthetic (0.02-0.08%) is injected. Often done in the same visit as your assessment, and usable where the tender area sits deeper. Dry needling (the same technique with nothing injected) is not offered here.
What the evidence shows
No study has tested any needling technique in elbow osteoarthritis. A search pairing dry needling, trigger point needling and trigger point injection with arthritis of the shoulder, elbow, wrist, thumb base and big toe returned 19 records, and none tested needling in an arthritic elbow. The elbow needling literature is about tennis elbow instead, and a randomised trial comparing ultrasound-guided dry needling with platelet-rich plasma there specifically excluded people with elbow osteoarthritis (Sharma, J Ultrasound 2024). A second pass restricted to clinical trials returned nothing at this joint.
Pairing reviewed 2026-10-01.
Where it fits
Only where the assessment finds a separate tender forearm or upper-arm muscle band reproducing part of the pain. It does not treat the arthritic joint.
Ultrasound-guided injections Guidance means the needle can be seen reaching the target. What goes into the needle depends on the diagnosis. No steroid trial here
What it involves
The injection is performed under ultrasound so the needle can be watched into the target structure. What is injected is decided by the diagnosis, and corticosteroid is used sparingly, for the reasons set out below.
What the evidence shows
The elbow is one of the few joints where an injection has been tested against a dummy injection and separated from the result at another joint in the same trial. Fifty people with elbow osteoarthritis received three injections of a diclofenac-hyaluronate conjugate or placebo over 12 weeks; the difference in pain was 0.61 points on an 11-point scale in favour of placebo (95% CI -0.41 to 1.62) (no benefit) while the hip arm of the same trial did benefit (-0.81, -1.48 to -0.13) (Kubo, BMC Musculoskelet Disord 2022). A search of 33 records found no randomised trial of corticosteroid at this joint. A review of primary elbow osteoarthritis describes occasional intra-articular corticosteroid as part of reasonable conservative care in earlier stages, which is opinion rather than trial evidence (Martinez-Catalan, J Clin Orthop Trauma 2021).
Pairing reviewed 2026-09-10.
Where it fits
Worth discussing to settle a painful phase or to help work out how much of the pain is coming from inside the joint, with the thinness of the evidence made clear. Loss of extension that limits function is a surgical conversation, not an injection one.
V-ACTOR vibration therapy (vibration therapy) Low-frequency vibration applied over tender muscle. Not a shockwave, despite sharing the machine. Plausible: no studies
What it involves
A vibration handpiece is moved over the tender muscle and fascia for a few minutes. It runs from the same STORZ MASTERPULS icon console as radial shockwave but is a separate handpiece delivering a different, gentler form of energy. No needles, no anaesthetic, no downtime.
What the evidence shows
No published clinical trial of this device in this condition. It is a vibration handpiece delivered from the same console as radial shockwave, and the rationale is myofascial rather than tendon- or bone-directed.
Pairing reviewed 2026-08-30.
Where it fits
A comfort measure used within a session where muscular tightness is limiting movement. Never the reason for the appointment, and not a substitute for the treatments that do have evidence.
Energy-based treatment options
Radial pressure wave, focused shockwave and EMTT have different targets and different evidence. They are assessed separately rather than treated as one category.
Radial or focused shockwave? Read the overviewRadial shockwave (radial pressure wave) Broad treatment across tender muscle and fascia, close to the surface. No studies at this joint
What it involves
A handpiece is moved over the tender tissue while ballistic pressure pulses are delivered, using a transmitter head chosen for the tissue, including heads shaped for fascia and for the muscle either side of the spine. The pulse is strongest at the skin and weakens with depth, so this is mainly a myofascial treatment, though it can reach deeper in some areas. No anaesthetic, no downtime, usually a course of sessions about a week apart.
What the evidence shows
Searching shockwave, shock wave, ESWT and radial shockwave against elbow osteoarthritis and elbow arthrosis returns no trial of either device in this condition, and the same search restricted to randomised trials returns nothing at this joint. The elbow shockwave evidence is all tennis and golfer's elbow, which is a tendon attachment problem rather than a worn joint, and even there a systematic review of 20 randomised trials of electrophysical treatments found the evidence for shockwave limited or conflicting (Dingemanse, Br J Sports Med 2013).
Pairing reviewed 2026-09-25.
Where it fits
Offered for tender forearm muscle and tendon attachment where examination finds those contributing, not for the joint itself. Stiffness and loose bodies in an arthritic elbow are a separate problem and shockwave does nothing for either.
Focused shockwave (ESWT) A true shock wave converging at depth: for tendon, joint, ligament and bone. Plausible: no studies
What it involves
A focused system generates an acoustic shock wave that converges at a focal point set at a defined depth, concentrating the energy where the target is. This is the form used for tendon, joint, ligament and bone. Typically four to six sessions about a week apart, no anaesthetic and no formal downtime.
What the evidence shows
No trial has tested shockwave for elbow osteoarthritis: searching shockwave, shock wave and ESWT against elbow osteoarthritis and elbow arthrosis returns no human study of either device. The case for it rests on other arthritic joints. Pooled trials at the knee favour shockwave over sham for pain and function (Tang, Int J Surg 2024), and at the hip a 148-person trial found focused shockwave better than sham (Şah, J Pers Med 2022).
Pairing reviewed 2026-10-04.
Where it fits
A reasonable option to try for arthritic elbow pain on the strength of the knee and hip trials, with the gap at this joint explained. It will not free an elbow that locks or catches: loose bodies and bony blocks are a surgical question.
EMTT (magnetotransduction therapy) High-energy magnetic pulses applied over the area. Usually painless, no contact. Plausible: no studies
What it involves
You sit with the applicator positioned over the area for a short session. It is usually painless and needs no gel or skin contact. It is usually given as a course, commonly alongside shockwave.
What the evidence shows
There are no published randomised trials of EMTT in this condition, or in any musculoskeletal condition, that could be identified. The supporting work is laboratory work: EMTT increased tenocyte proliferation, migration and collagen expression in cultured human tendon cells (Mancini, Int J Mol Sci 2025). The nearest human evidence for a related electromagnetic therapy is negative. A randomised trial of pulsed electromagnetic field therapy added to eccentric exercise for Achilles tendinopathy found no improvement in outcome scores or tendon neovascularity over eccentric exercise alone (Ko, Orthop J Sports Med 2024).
Pairing reviewed 2026-08-30.
Where it fits
Offered only as an adjunct alongside treatment that does have evidence, never as the plan itself, and only after that gap is explained. Much of the EMTT literature is manufacturer-affiliated, which is part of why it is described this way.
Biologic and joint injection options
Each injection is assessed independently for the named diagnosis. Cost, uncertainty, likely benefit, risks and alternatives are part of the decision.
Platelet-rich plasma (PRP) Your own blood, concentrated and injected under ultrasound guidance. Plausible: no studies
What it involves
Blood is taken from your arm, spun to concentrate the platelets, and injected into the target under ultrasound guidance in the same appointment.
What the evidence shows
No clinical study of PRP in an arthritic human elbow was found. Searches on 8 October 2026 pairing platelet-rich plasma with the elbow and with osteoarthritis or arthritis returned 23 records, and a randomised-trial pass returned two; none was a trial, cohort, case series or case report of PRP injected into an arthritic elbow joint. The elbow PRP literature is about tennis elbow and the ulnar collateral ligament. The only studies at this joint are veterinary: in 19 dogs with elbow osteoarthritis a single joint injection of PRP with fat-derived cells changed one of seven gait measures at a year, and the authors could not confirm a benefit (Bergström, Vet Sci 2024). The rationale therefore rests on the knee, where pooled placebo-controlled trials favour PRP (Bensa, Am J Sports Med 2025), and that result has not carried over reliably to other joints - at the ankle PRP was no better than saline in a trial of 100 people (Paget, JAMA 2021).
Pairing reviewed 2026-10-08.
Where it fits
Can be discussed on the knee-based rationale for a painful arthritic elbow that has not responded to simpler care, with the complete absence of human studies at this joint, the cost and the uncertainty all stated beforehand. Not a first-line option.
Prolotherapy (dextrose) A course of dextrose injections into and around the structure and its attachments. Plausible: no studies
What it involves
Hypertonic dextrose is injected at the tender ligament and tendon attachments, and into the joint where relevant, usually as a series of treatments a few weeks apart.
What the evidence shows
No human study of prolotherapy in elbow arthritis. A search on 12 October 2026 for dextrose or prolotherapy in arthritis of the elbow, wrist or big toe returned four records. The only elbow trial was in dogs, a small placebo-controlled pilot in elbow and knee arthritis that found no benefit (Sherwood, J Am Anim Hosp Assoc 2017), which says nothing either way about people. The human trials of dextrose injection into an arthritic joint are in the knee and the fingers (Chen, Clin Rehabil 2022; Reeves, J Altern Complement Med 2000).
Pairing reviewed 2026-10-12.
Where it fits
Prolotherapy is offered here and can be discussed for elbow arthritis pain that persists despite activity changes and exercise, with the absence of studies at the elbow explained. It is not expected to restore lost movement from bone spurs or loose bodies.
Viscosupplementation (hyaluronic acid) A gel-like injection into an arthritic joint. Widely used, and genuinely contested. No benefit shown in small studies
What it involves
One or a short series of hyaluronic acid injections into the joint under ultrasound guidance.
What the evidence shows
Searched PubMed for the same hyaluronic acid terms with elbow and osteoarthritis, arthritis or arthrosis (20 records; 4 trials, no systematic review; 4 animal studies excluded). The only placebo-controlled data come from a diclofenac-hyaluronate conjugate rather than plain hyaluronic acid: in 50 people with elbow arthritis, three injections were no better than placebo at 12 weeks (Kubo, BMC Musculoskelet Disord 2022). With plain hyaluronic acid, a series of 19 elbows with arthritis after injury had slight short-term pain relief at three months and no benefit in any elbow at six (van Brakel, Arthroscopy 2006). No trial of plain hyaluronic acid against placebo or cortisone at the elbow was found. The evidence is small, but what there is points to no benefit.
Pairing reviewed 2026-10-26.
Where it fits
Not a first-line option for elbow arthritis: the small studies that exist found no lasting benefit. Activity modification and strengthening come first, with a guided cortisone or other injection considered if needed.
Nerve-targeted options
Relevant when examination identifies a superficial neuropathic pattern or a compressed peripheral nerve, not simply because pain is present.
Lyftogt perineural therapy (perineural injection therapy) A series of small dilute dextrose injections just under the skin, over tender superficial nerves. Only if relevant
What it involves
Small injections of low-concentration dextrose, usually 5%, placed just beneath the skin along tender superficial nerves. Given as a series of short sessions.
What the evidence shows
Perineural dextrose evidence is concentrated in diagnosed peripheral compression neuropathies, particularly the upper limb; no direct evidence was identified for this diagnosis itself. Condition reviewed: elbow osteoarthritis.
Evidence source: Perineural dextrose for upper-limb entrapment neuropathy review (2025)
Pairing reviewed 2026-08-30.
Where it fits
For elbow osteoarthritis, perineural treatment may be considered only if a separate superficial neuropathic pain pattern is found on examination. It is not treatment of the primary diagnosis.
Ultrasound-guided nerve hydrodissection Fluid placed around a nerve to free it from the surrounding tissue. Only if relevant
What it involves
Under ultrasound, fluid is placed in the plane around the nerve to separate it from the tissue that is tethering or compressing it.
What the evidence shows
Hydrodissection evidence is concentrated in ultrasound-confirmed peripheral nerve entrapment, especially carpal tunnel syndrome; no direct evidence was identified for this diagnosis itself. Condition reviewed: elbow osteoarthritis.
Evidence source: Buntragulpoontawee et al., hydrodissection injectate review (2021)
Pairing reviewed 2026-08-30.
Where it fits
For elbow osteoarthritis, hydrodissection may be considered only if ultrasound and examination identify a separate compressed or tethered peripheral nerve. It is not treatment of the primary diagnosis.
This is general information only and suitability is assessed individually. Treatments with limited or condition-dependent evidence may still be discussed, but only with clear explanation of the uncertainty, the expected benefit, risks, cost and alternatives. Red flags, progressive neurological symptoms or suspected serious pathology require a different pathway.
Every treatment above is described in full on the non-surgical treatments page, including what each one is used for and what the evidence supports. Ratings apply to the named diagnosis; an adjacent muscle, tendon, joint or nerve problem is assessed as a separate target. The method behind the ratings, and the treatments not offered, are set out on the evidence page.
Corticosteroid injection is reviewed separately for each diagnosis.
Cortisone reliably reduces pain in the short term, and that can be genuinely useful when pain is stopping you sleeping or moving enough to rehabilitate. Beyond that window the picture changes. A systematic review of 41 randomised trials and 2,672 participants found that corticosteroid injection reduced pain in the short term but that the effect reversed at intermediate and long term; in pooled analysis for lateral epicondylalgia the short-term effect was large (SMD 1.44, 95% CI 1.17 to 1.71) while no intervention was favoured at 26 weeks (-0.40, -0.67 to -0.14) and at 52 weeks (-0.31, -0.61 to -0.01) (Coombes, Lancet 2010). In a randomised trial in lateral epicondylalgia, 83 per cent of the corticosteroid group had completely recovered or much improved at one year against 96 per cent given a placebo injection, and recurrence ran at 54 per cent against 12 per cent; adding physiotherapy made no significant difference at one year (Coombes, JAMA 2013). In joints, repeated corticosteroid injections have been associated with cartilage loss. It does not repair anything.
So treatment plans are not built around it. Where an injection is the right call, the specific diagnosis and target are reviewed, what is being injected and why is discussed, the number is kept low, and it is paired with the loading work that changes the longer-term course.
When it might still be considered
- Pain severe enough to block rehabilitation
- A clear inflammatory or bursal target on imaging
- A specific short-term goal: a trip, a procedure, a return to work
- Diagnostic use, where the response shows where the pain is coming from
When a cortisone injection is worth doing, and when it is not
Other elbow, wrist & hand conditions
Pain in the same area can come from more than one source, and the label matters less than what the examination and history point to. These are the other guides for this region.
Frequently asked questions
How is elbow osteoarthritis diagnosed?
What does non-surgical treatment involve?
When is surgery considered?
Ready for a clearer plan for your back or musculoskeletal pain?
Book an assessment with Dr Joshua Hatch.
Your assessment focuses on understanding the likely source of your pain and the most appropriate non-surgical options for your diagnosis, with the aim of reducing pain and improving function.
You must have your own regular GP before booking. This service works alongside your GP for focused care. Booking requirements.
Book an appointment